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Nedd4 is an E3 ubiquitin ligase that has an essential role in craniofacial development. However, how and
when Nedd4 controls skull formation is ill deﬁned. Here we have used a collection of complementary
genetic mouse models to dissect the cell-autonomous roles of Nedd4 in the formation of neural crest cell
derived cranial bone. Removal of Nedd4 speciﬁcally from neural crest cells leads to profound craniofacial
defects with marked reduction of cranial bone that was preceded by hypoplasia of bone forming os-
teoblasts. Removal of Nedd4 after differentiation of neural crest cells into progenitors of chondrocytes
and osteoblasts also led to profound deﬁciency of craniofacial bone in the absence of cartilage defects.
Notably, these skull malformations were conserved when Nedd4 was speciﬁcally removed from the
osteoblast lineage after speciﬁcation of osteoblast precursors from mesenchymal skeletal progenitors.
We further show that absence of Nedd4 in pre-osteoblasts results in decreased cell proliferation and
altered osteogenic differentiation. Taken together our data demonstrate a novel cell-autonomous role for
Nedd4 in promoting expansion of the osteoblast progenitor pool to control craniofacial development.
Nedd4 mutant mice therefore represent a unique mouse model of craniofacial anomalies that provide an
ideal resource to explore the cell-intrinsic mechanisms of neural crest cells in craniofacial morphogen-
esis.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Craniofacial malformations represent a signiﬁcant clinical issue,
with many cases requiring highly invasive and recurring surgical
interventions throughout life. Unfortunately, the vast majority of
these disorders have unknown genetic or pathological origin.
These highly prevalent disorders manifest as a result of the com-
plex array of cellular interactions and morphogenetic events re-
quired for correct development of the craniofacial skeleton. In
contrast to the mesodermal origin of the axial and appendicular
skeleton, the mammalian skull requires the unique contribution of
cells from the cranial neural crest (Trainor, 2013). In addition, the
calvaria and the bones of the face form primarily through the
process of intramembranous ossiﬁcation in which mesenchymal
progenitors differentiate directly into bone-forming osteoblasts
without a cartilage precursor (Percival and Richtsmeier, 2013).
Identifying the molecular mechanisms by which neural crest cells
differentiate into osteoblasts and bone is critical to our under-
standing of craniofacial development and the origins and potential
treatments for craniofacial birth defects.
Cranial neural crest cells are multipotent cells that arise from
the dorsal neural folds during early embryonic developmentInc. This is an open access article u
(Q. Schwarz).(Trainor, 2013). Following delamination from the neural tube,
cranial neural crest cells migrate vast distances into the facial
primordia where they receive instructive signals to initiate a
transcriptional programme that ultimately leads to their differ-
entiation into bone and cartilage (Jeong et al., 2004). In the ﬁrst of
a series of differentiation steps, neural crest cells entering the fa-
cial primordia form mesenchymal progenitors of bone and carti-
lage. Cell-type speciﬁcity is later initiated through the expression
of the HMG box transcription factor Sox9 in cartilage precursors (Bi
et al., 2001) or the sequential activity of the runt family member
Runx2 (Komori et al., 1997) and the zinc ﬁnger transcription factor
Osterix (Osx) (Nakashima et al., 2002) in osteoblast precursors. The
outcome of these transcriptional programmes is the progression of
precursor cell differentiation into bonaﬁde chondroctyes or os-
teoblasts that in turn secrete extracellular matrix components and
mineral speciﬁc to cartilage or bone.
While our knowledge of neural crest cell and cranial bone
formation is biased toward the roles of transcription factor net-
works acting downstream of morphogenic gradients, intrinsic
roles for post-translational modiﬁcations in neural crest cells are
also coming to light (Wiszniak et al., 2013; Vermillion et al., 2014).
Ubiquitination is a post-translational modiﬁcation that instructs
functional changes in target proteins by controlling degradation,
localisation or biochemical properties (Rotin and Kumar, 2009).
We recently identiﬁed an essential role for ubiquitination in neural
crest cell development by demonstrating that the E3 ubiquitinnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Wiszniak et al., 2013). Nedd4 is expressed in neural crest cells as
they delaminate from the neural tube and Nedd4 / mice have
profound deﬁciency of cranial ganglia and neural crest cell-derived
cranial bones, as well as milder reductions in bone in the axial
skeleton. As Nedd4 is essential for maintaining neural crest cell
stem-cell identity and survival, our results suggested that the
craniofacial defects may arise from a lack of neural crest cells at
earlier developmental time points. However, whether Nedd4 isNedd4fl/+
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Fig. 1. Loss of Nedd4 in neural crest cells and derivatives causes craniofacial defects. E1
Nedd4ﬂ/þ wildtype embryo. B: Loss of a single allele of Nedd4 in Nedd4ﬂ/ embryos caus
crest-derived tissue in Wnt1-Cre; Nedd4ﬂ/þ embryos similarly causes a mild reduction in
in Wnt1-Cre; Nedd4ﬂ/ embryos causes severe hypoplasia of craniofacial bone. bas, bas
lamina obturans; md, mandible; mk, Meckel's cartilage; mx, maxillary; nc, nasal capsule
tympanic. Scale bar¼1 mm.cell-autonomously required by neural crest cells or whether early
neural crest cell deﬁciency underpins craniofacial defects re-
mained unresolved. Here we have removed Nedd4 at various
stages of cranial neural crest cell and bone development using Cre/
LoxP technologies to answer these questions.
Consistent with our analyses in Nedd4 / embryos we found
that mice lacking Nedd4 speciﬁcally in neural crest cells had
pronounced bone deﬁciency in the absence of notable cartilage
defects. Our analyses at earlier embryonic stages further suggestNedd4fl/-
Wnt1-Cre; Nedd4fl/-
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7.5 littermate skulls stained with Alizarin red (bone) and Alcian blue (cartilage). A:
es a mild reduction in bone. C: Loss of a single allele of Nedd4 speciﬁcally in neural
neural crest derived bone. D: Complete lack of Nedd4 in neural crest-derived tissue
isphenoid; boc, basioccipital; eo, exoccipital; fb, frontal bone; ipa, interparietal; lo,
; pa, parietal; pal, palatal; pmx, premaxillary; ppmx, palatal process maxillary; tym,
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tion in osteoblast progenitors. Removal of Nedd4 after the initial
speciﬁcation of neural crest cells toward mesenchymal progenitors
of bone and cartilage, or after differentiation into osteoblast pre-
cursors also lead to pronounced deﬁciency of craniofacial bone,
akin to our report in Nedd4 / embryos. Analysis of osteoblast
growth dynamics demonstrated signiﬁcant reductions in cell
proliferation and altered osteogenic differentiation. In addition to
a role in maintaining the progenitor pool of neural crest cells at
early stages of development, our results therefore identify a novel
cell-autonomous role for Nedd4 in promoting proliferation of os-
teoblast precursors and their terminal differentiation into deﬁni-
tive osteoblasts and osteocytes. These ﬁndings further demon-
strate that bone hypoplasia associated with Nedd4 deﬁciency
arises from aberrant osteoblast formation rather than a reduction
in neural crest cell numbers at earlier stages of development.2. Results
2.1. Loss of Nedd4 in neural crest-derived tissue causes craniofacial
defects
We have previously reported that complete loss of Nedd4 in
Nedd4 / mice causes craniofacial defects, with severe hypoplasia
of neural crest-derived intramembranous bone (Wiszniak et al.,
2013). This raised the hypothesis that given the developmental
origin of these cranial bones, Nedd4 may be required cell-Nedd4fl/-
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Fig. 2. Bone formation is reduced at E15.5 inWnt1-Cre; Nedd4ﬂ/ mutants. Serial frontal
with Von Kossa and Alcian Blue (left panels) to mark mineralisation and cartilage resp
Equivalent sections of control and mutant embryos are shown of the premaxilla (top), m
mutants show less mineralised bone and ALP staining, whereas cartilage developmen
mandible; mk, Meckel's cartilage; tb, toothbud; t, tongue. Scale bar¼200 μm.autonomously in neural crest cells for correct craniofacial bone
development. To address this, we removed Nedd4 speciﬁcally in
the neural crest cell lineage by crossing a ﬂoxed Nedd4 allele to the
Wnt1-Cre driver which is widely used for neural crest cell-speciﬁc
gene deletion (Jiang et al., 2000). Consistent with our previous
study, we found that deletion of a single copy of Nedd4, either in
the whole embryo (Nedd4ﬂ/ , Fig. 1B) or speciﬁcally in the neural
crest (Wnt1-Cre; Nedd4ﬂ/þ , Fig. 1C) caused a mild general hypo-
plasia of bones in the skull at embryonic day (E) 17.5. Mild bone
hypoplasia also persisted into adulthood in Nedd4þ /- animals
compared to wildtype littermates (Supp. Fig. 1). However, com-
plete removal of Nedd4 in all neural crest-derived tissue (Wnt1-
Cre; Nedd4ﬂ/ , Fig. 1D or Wnt1-Cre; Nedd4ﬂ/ﬂ, Supp. Fig. 2) caused
severe hypoplasia of craniofacial bone at E17.5, as well as clefting
of the palate (Supp. Fig. 3A). Notably, the frontal bone, premaxilla,
maxilla, tympanic, basisphenoid and palatine bone were markedly
reduced. In contrast to Nedd4ﬂ/ mice, the mesodermal derived
bones, such as the parietal, were less affected in Wnt1-Cre;
Nedd4ﬂ/þ embryos, which is expected given Wnt1-Cre does not
drive expression and hence Nedd4 knockout in these tissues. The
mild hypoplasia of mesodermal-derived intramembranous bones
observed in Wnt1-Cre; Nedd4ﬂ/þ animals likely reﬂects a slight
developmental delay in these embryos compared to the wildtype
controls, given that the parietal and interparietal bones are only
just beginning to ossify at E17.5, and variability of ossiﬁcation in
these bones is evident between wildtype littermates. Taken to-
gether, these results are consistent with our previous study, and as
such the craniofacial defects observed in Nedd4 / mice areWnt1-Cre; Nedd4fl/-
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Bone formation was further examined earlier in development
at E15.5 by histological analyses. Sections of Nedd4ﬂ/ control and
Wnt1-Cre; Nedd4ﬂ/ mutant embryos stained with Von Kossa to
mark mineralised bone and Alcian blue to mark cartilage revealed
a dramatic reduction in bone formation throughout the skull, in-
cluding the premaxilla, maxilla and mandible, with negligible ef-
fects on cartilage development (Fig. 2). Staining of serial sections
with alkaline phosphatase (ALP), a marker of osteoblast activity,
also demonstrated a marked reduction of osteoblasts in Wnt1-Cre;
Nedd4ﬂ/ mutant embryos (Fig. 2), which likely underlies the re-
duced bone deposition in these mutants.Nedd4fl/+
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Fig. 3. Nedd4 is required in the osteoblast lineage for craniofacial bone formation. E17
Nedd4ﬂ/þ wildtype embryo. B: Consistent with previous analyses, loss of a single allele
allele of Nedd4 speciﬁcally in osteoblasts in Osx-Cre; Nedd4ﬂ/þ embryos similarly cause
Nedd4ﬂ/ embryos causes severe hypoplasia of craniofacial bone. bas, basisphenoid; boc,
md, mandible; mk, Meckel's cartilage; mx, maxillary; nc, nasal capsule; pa, parietal; pal
bar¼1 mm.2.2. Nedd4 is required in the osteoblast lineage for craniofacial bone
formation
Given Wnt1-Cre is expressed in the earliest precursors of the
craniofacial bones, the neural crest, beginning around E8.5, we
sought to deﬁne the critical time at which Nedd4 plays a role in
cranial bone development. Neural crest cells delaminate from the
neural tube and migrate into the facial primordia where they form
mesenchymal condensations at sites of the future facial bones. As
development progresses, these mesechymal cells differentiate into
pre-osteoblasts, and then osteoblasts, which function to deposit
bone matrix that acts as a substrate for subsequent mineralisation
(Komori, 2006).Nedd4fl/-
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of Nedd4 in Nedd4ﬂ/ embryos causes a mild reduction in bone. C: Loss of a single
s a mild reduction in bone. D: Complete lack of Nedd4 in osteoblasts in Osx-Cre;
basioccipital; eo, exoccipital; fb, frontal bone; ipa, interparietal; lo, lamina obturans;
, palatal; pmx, premaxillary; ppmx, palatal process maxillary; tym, tympanic. Scale
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after neural crest cell formation and migration into the facial pri-
mordia, we removed Nedd4 in the facial mesenchyme using the
Prx1-Cre driver, which directs Cre expression in mesenchymal
lineages destined to form bone and cartilage (Logan et al., 2002).
Similar to the phenotype observed in Nedd4 / and Wnt1-Cre;
Nedd4ﬂ/ mutants (Supp. Fig. 4), we observed a dramatic reduction
in cranial neural crest-derived and intramembranous bone in Prx1-
Cre; Nedd4ﬂ/ mutants (Supp. Fig. 5). Speciﬁcally, there was a
marked reduction of the frontal bone, premaxilla, maxilla, tym-
panic, basisphenoid and palatine bone in these mice. This suggests
that the cranial bone defects observed in Nedd4 / mice are un-
likely due to a defect in early neural crest cell development, and
likely lie later in the bone formation pathway.
To analyse the role of Nedd4 in later stages of bone develop-
ment, we removed Nedd4 speciﬁcally in the osteoblast lineage
using the Osx-Cre driver (Rodda and McMahon, 2006) which di-
rects expression of Cre in pre-osteoblasts beginning around E12.5
(Supp. Fig. 6). We ﬁrst analysed craniofacial bone formation at
E17.5. Consistent with aforementioned results, we observed a mild
general hypoplasia of bones with loss of a single allele of Nedd4
(Nedd4ﬂ/ and Osx-Cre; Nedd4ﬂ/þ , Fig. 3B and C), but lack of both
Nedd4 alleles speciﬁcally in pre-osteoblasts (Osx-Cre; Nedd4ﬂ/ ,
Fig. 3D or Osx-Cre; Nedd4ﬂ/ﬂ Supp. Fig. 2) caused severe hypoplasia
of cranial bone. There were dramatic reductions in neural crest
derived structures including the frontal bone, premaxilla, maxilla,
tympanic, basisphenoid, lamina obturans, palatine bone and
mandible in these mice. However, in contrast to Wnt1-Cre;Nedd4fl/-
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Fig. 4. Bone formation is reduced at E15.5 in Osx-Cre; Nedd4ﬂ/ mutants Serial frontal sec
Von Kossa and Alcian Blue (left panels) to mark mineralisation and cartilage respectively,
sections of control and mutant embryos are shown of the premaxilla (top), maxilla (midd
less mineralised bone and ALP staining, whereas cartilage development is unaffected.
Meckel's cartilage; tb, toothbud; t, tongue. Scale bar¼200 μm.Nedd4ﬂ/ embryos there was no palatal clefting in Osx-Cre;
Nedd4ﬂ/ or Prx1-Cre; Nedd4ﬂ/ mutants (Supp. Fig. 3). In addition
to these neural crest derived bone defects, there was also deﬁ-
ciency in the mesodermal derived parietal bones (Fig. 3D). Bone
formation was further examined earlier in development at E15.5
by Von Kossa, Alcian blue and ALP staining. Consistent with the
analyses performed on Wnt1-Cre; Nedd4ﬂ/ mutants, Osx-Cre;
Nedd4ﬂ/ mutants demonstrated a reduction in formation of mi-
neralised bone and osteoblast staining compared to Nedd4ﬂ/
controls (Fig. 4 and Supp. Fig. 4). This identiﬁes an important role
for Nedd4 in craniofacial development after the onset of bone
progenitor speciﬁcation.
In our previous publication, we reported aberrant cranial
neural crest cell death in cells of the rhombomere 2 (r2) migrating
stream in Nedd4 / embryos, and hypothesised that neural crest
cell deﬁciency due to increased cell death may underlie the re-
duced cranial bone formation in these mice (Wiszniak et al., 2013).
To explore whether the increased neural crest cell death observed
in Nedd4 / embryos was cell-autonomous, we analysed cleaved-
Caspase 3 expression in Wnt1-Cre; Nedd4ﬂ/ mutants at E9.5.
Consistent with our previous results, neural crest cell death was
similarly observed in Wnt1-Cre; Nedd4ﬂ/- mutants (Supp. Fig. 7A).
Concomitantly, at E11.5, the trigeminal ganglia, which is in part
derived from neural crest cells of the r2 stream, was signiﬁcantly
smaller in size in Wnt1-Cre; Nedd4ﬂ/ embryos compared to con-
trols (Supp. Fig. 7B). In contrast, formation of the trigeminal
ganglia was unaffected in Osx-Cre; Nedd4ﬂ/ embryos (Supp.
Fig. 7C). Since the craniofacial bone defects of Nedd4 / embryosOsx-Cre; Nedd4fl/-
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le) and mandible (bottom). Compared to controls, Osx-Cre; Nedd4ﬂ/ mutants show
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development cascade, we conclude that the primary role of Nedd4
in craniofacial development lies in the formation of bone from pre-
osteoblasts rather than maintaining neural crest cell survival at
earlier stages of development. Taken together, our previous and
current results therefore support a dual role for Nedd4 in neural
crest and craniofacial development; in promoting neural crest cell
survival in cells destined to form the trigeminal ganglia, and later
in the proliferation of pre-osteoblast bone progenitors.
2.3. Osteoblast progenitors are reduced in Osx-Cre; Nedd4ﬂ/
embryos
Considering the marked reduction in bone formation and os-
teoblasts at E15.5, we sought to determine the onset of defective
bone development in Osx-Cre; Nedd4ﬂ/ mutants. The Osx-Cre
driver produces a Cre-GFP fusion protein (Rodda and McMahon,
2006) which allows for visualisation of the Osx-Cre expression
domain by examining GFP native ﬂuorescence or immunostaining
with anti-GFP antibodies. The earliest developmental time point at
which we could detect Cre-GFP protein was E12.0. We compared
Cre-GFP expression in sections of Osx-Cre; Nedd4ﬂ/þ control and
Osx-Cre; Nedd4ﬂ/ mutant embryos at E12.5, E13.5 and E15.5
(Fig. 5). At E12.5 there was comparable expression of Cre-GFP
between control and mutant embryos (Fig. 5A and quantiﬁed inOsx-Cre; Nedd4fl/+ Osx-Cre; Nedd4fl/- Osx-Cre; Nedd4fl/+
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Fig. 5. Osteoblast progenitors are reduced in Osx-Cre; Nedd4ﬂ/ mutants from E13.5. T
visualisation of Osx expressing osteoblast progenitor cells. A–C: Frontal sections of Osx-C
for GFP. Sections through the premaxilla are shown in left panels, sections through the
shown in right panels. A: At E12.5, the area of GFP expression is mildly reduced in m
progenitors is greatly reduced. C: Similarly at E15.5 the area of GFP expressing cells is
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control and mutant embryos were compared, with at least 5 sections per bone per an
po0.0001, *** po0.001 ** po0.01, * po0.05, ns¼not signiﬁcant. Error bars representD), suggesting the initial speciﬁcation of pre-osteoblasts in mutant
embryos occurs normally. However, from E13.5 onwards, the area
of Cre-GFP positive cells was markedly reduced in Osx-Cre;
Nedd4ﬂ/ mutants compared to controls (Fig. 5B, C and quantiﬁed
in E, F). This suggests that following speciﬁcation, there is loss of
osteoblasts in Osx-Cre; Nedd4ﬂ/ mutants, which likely underpins
the reduction in mineralised bone seen later in development.
We further examined osteoblast progenitor development in
Osx-Cre; Nedd4ﬂ/ mutants by in situ hybridisation for the pre-
osteoblast markers Runx2 and Osx, and the committed osteoblast
markers Col1a1 and BSP. At E13.5, expression of all markers was
dramatically reduced in Osx-Cre; Nedd4ﬂ/ mutants compared to
Nedd4ﬂ/ controls (Fig. 6A). Consistently, at E15.5, Col1a1 expres-
sion was severely reduced in mutants (Fig. 6B), as well as BSP
expression at E15.5 (Fig. 6C) and E18.5 (Fig. 6D).
2.4. Reduced pre-osteoblast proliferation underlies bone hypoplasia
in Osx-Cre; Nedd4ﬂ/ mutants
Given the reduction in Cre-GFP-positive osteoblast progenitors
observed in Osx-Cre; Nedd4ﬂ/ mutants at E13.5 and E15.5 (Fig. 5),
we hypothesised that reduced cell proliferation or aberrant cell
death may underlie this observed reduction in Cre-GFP cells, and
hence contribute to the bone hypoplasia observed in later devel-
opment. We analysed cell proliferation and death by stainingOsx-Cre; Nedd4fl/-
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Nedd4ﬂ/ mutant embryos for EdU incorporation, phospho-his-
tone H3 (PHH3), TUNEL and cleaved-Caspase 3. Analysis of EdU
incorporation at E12.5 revealed a decrease in cell proliferation of
25% in mutants compared to controls (Fig. 7A and Supp. Fig. 8A).
Similarly, analysis of cell proliferation by immunostaining for
PHH3 (which marks cells in G2/M phase) revealed a dramatic
decrease in proliferation of 50% at E12.5, followed by consistent
but more modest decreases in proliferation at E13.5 and E15.5
(Fig. 7B and Supp. Fig. 8B). For all analyses, proliferation mea-
surements were made for multiple cranial bones including the
premaxilla, maxilla, mandible, and frontal bones, and combined
into an average of total bones (Fig. 7). For measurements divided
into individual bones, see Supp. Fig. 8. At all stages examined,
there were no signiﬁcant differences in cell death between control
and mutant embryos by either TUNEL or Caspase 3 staining
(Fig. 7C, D, Supp. Figs. 8C,D and 9 for individual bones). This sug-
gests that the lack of bone observed in later development, and the
reduction in osteoblasts observed from E13.5 onwards is caused bya failure of correct proliferation of osteoblast progenitors at a
critical time window between E12.5 and E13.5 in Osx-Cre;
Nedd4ﬂ/ embryos. Therefore, Nedd4 likely plays an important role
in positively regulating pre-osteoblast proliferation between E12.5
to E13.5. This is consistent with the expression proﬁle of Nedd4,
which is broadly expressed throughout development, but is highly
expressed in the pre-osteoblast mesenchyme at E13.5, with re-
duced expression later in development at E15.5 (Supp. Fig. 10).
Bone morphogenic proteins (BMPs) play important roles in
bone formation by inducing osteoblast differentiation (reviewed in
(Chen et al., 2012)). BMPs signal via activation of the intracellular
signalling molecules known as SMADs, in particular by phos-
phorylating and activating SMAD1/5/8. Nedd4 has previously been
shown to negatively regulate BMP signalling via interacting di-
rectly with SMAD1 to promote its ubiquitination and proteosomal
degradation (Kim et al., 2011). Consequently, siRNA knockdown of
Nedd4 in human vascular smooth muscle cells increased phospho-
SMAD1 and ALP activity, and induced calciﬁcation of these cells
(Kim et al., 2011). Given this, and although in a different cellular
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Fig. 7. Reduced pre-osteoblast proliferation, without aberrant cell death, underlies bone hypoplasia in Osx-Cre; Nedd4ﬂ/ mutants. Cell proliferation and death was examined
in Osx-Cre; Nedd4ﬂ/þ (control) and Osx-Cre; Nedd4ﬂ/ (mutant) embryos by quantitating the number of positive cells per mm2 of GFP-positive cells in tissue sections. A:
pregnant dams were pulsed with EdU 2 hours prior to embryo harvest at E12.5 to assess cell proliferation. There is a signiﬁcant reduction in EdU-positive cells in pre-
osteoblasts in mutant embryos. B: Control and mutant embryos at E12.5, E13.5 and E15.5 were immunostained for phospho-histone H3 (PHH3) to assess cell proliferation.
There is a marked reduction in proliferation in mutant embryos at E12.5, with signiﬁcant reductions in proliferation also observed at E13.5 and E15.5. C: E12.5 sections were
stained with the TUNEL method to assess cell death, with no signiﬁcant differences observed between control and mutant embryos. D: Cell death was examined by cleaved
caspase 3 immunostaining at E12.5, E13.5 and E15.5. No signiﬁcant differences were observed between control and mutant embryos at all stages examined. Statistical
signiﬁcance was determined by Student's t-test. **** po0.0001, * po0.05, ns¼not signiﬁcant. Error bars represent SEM.
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induce premature differentiation via upregulation of phospho-
SMAD1, at the expense of proliferation and expansion of the
progenitor pool. Immunostaining of E12.5, E13.5 and E15.5 em-
bryos for phospho-SMAD1/5/8 revealed no upregulation of phos-
pho-SMAD in Cre-GFP-positive osteoblast progenitors in Osx-Cre;
Nedd4ﬂ/ mutants compared to controls (Supp. Fig. 11). Therefore
it is unlikely that the reduced proliferation of preosteblasts in Osx-
Cre; Nedd4ﬂ/ embryos may be explained by premature differ-
entiation of these cells.3. Discussion
Here we have used genetic approaches to dissect the roles of
the ubiquitin ligase Nedd4 in craniofacial development. Our pre-
vious analysis of Nedd4 / mice demonstrated that Nedd4 is es-
sential for intramembranous bone formation, however the timing
at which it contributed to this process remained unknown. Indeed,
based on our ﬁndings of reduced cranial neural crest cell viability
in the absence of Nedd4, our previous data suggested a model in
which the craniofacial defects may arise from an insufﬁcient po-
pulation of cranial neural crest cells at earlier developmental time
points. Consistent with this hypothesis, we found that mice lack-
ing Nedd4 in neural crest cells (Wnt1-Cre; Nedd4ﬂ/) had aberrant
neural crest cell death and replicated the full repertoire of cra-
niofacial defects observed in Nedd4 / mice.
However, since the craniofacial bone is of neural crest cell
origin, the Wnt1-Cre; Nedd4ﬂ/ genetic cross does not distinguish
between early roles for Nedd4 in neural crest cell viability or later
roles for Nedd4 in osteoblast formation or bone deposition. Toaddress this, we next generated mice in which Nedd4 was ge-
netically deleted at later stages of bone development. Removal of
Nedd4 with Prx1-Cre also replicated the full craniofacial pheno-
type of Nedd4 / embryos. This result therefore demonstrates a
primary role for Nedd4 in intramembranous ossiﬁcation after the
onset of neural crest cell speciﬁcation toward chondrocyte or os-
teoblast identity. The Wnt1-Cre and Prx1-Cre crosses both remove
Nedd4 from mesenchyme with both osteoblast and chondrocyte
potential, however, neither line had notable cartilage defects. This
further suggests Nedd4 plays a critical role in bone development
after the speciﬁcation of mesenchyme toward an osteoblast or
chondrocyte lineage. Consistent with this notion, removal of
Nedd4 with Osx-Cre also replicated the craniofacial bone hypo-
plasia of the other Nedd4 deﬁcient lines. Since Osx-Cre only be-
comes expressed after the onset of mesenchymal differentiation
into osteoblast precursors, this result further demonstrates that
Nedd4 has an essential role in osteoblast formation and bone
deposition.
Our previous analysis of Nedd4 / embryos identiﬁed sig-
niﬁcantly increased neural crest cell death in the craniofacial re-
gion soon after delamination, and this was conﬁrmed to be a cell-
autonomous effect in Wnt1-Cre; Nedd4ﬂ/ embryos. However,
since the craniofacial bone deﬁciency was also observed in Prx1-
Cre and Osx-Cre; Nedd4ﬂ/ mutant embryos, which do not induce
Nedd4 knockout until after neural crest cell migration in to the
facial primordia, our new data suggest that this early neural crest
cell death does not underlie craniofacial bone defects. Rather, our
analysis of the trigeminal ganglia may suggest that the cranial
neural crest cell death identiﬁed at E9.5 is restricted to cells of the
neuronal and glial lineage. Whether aberrant cell death in
Nedd4 / mice leads to deﬁciencies of other neural crest cell
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cardiac outﬂow tract remains to be explored.
Our results suggest that reduced proliferation of osteoblast
precursors at a critical time window of E12.5–15.5 represents part
of the cellular mechanism underlying bone deﬁciency in mice
lacking Nedd4. Consistent with a reduction in EdU incorporation
and PHH3-positve proliferative cells at each age examined, we also
observed increasing severity in the hypoplasia of pre-osteoblasts
(Runx2, Osx and Cre-GFP positive cells), osteoblasts (Col1a1, BSP
and ALP positive cells) and bone deposition (von kossa and Ali-
zarin red staining) as development progressed. While this high-
lights an essential role for Nedd4 in maintaining or promoting the
expansion of the pre-osteoblast progenitor pool, our results may
also suggest that progression of osteoblast development is ar-
rested in the absence of Nedd4. Thus, while we observed a mild
reduction in pre-osteoblast proliferation and Cre-GFP positive
cells, there was a profound lack of bone deposition and Col1a1
expression at later stages of development.
Progression of immature mesenchymal cells along the osteo-
blast lineage is controlled by expression of the master regulator
Runx2. Runx2, in turn, promotes expression of Osx, and together
these transcription factors are essential for osteoblast differentia-
tion (Komori, 2006). The importance of these transcription factors
in bone formation is clearly evident from the analysis of Runx2 and
Osx knockout mice. In the absence of Runx2, Osx fails to be ex-
pressed and bone development is arrested at the pre-osteoblast
stage (Komori et al., 1997; Otto et al., 1997). In the absence of Osx,
Runx2 is expressed in pre-osteoblasts but ossiﬁcation is completely
blocked (Nakashima et al., 2002). Notably in Runx2 and Osx
knockout mice, the progenitor pool of pre-osteoblasts is compar-
able between knockout and control embryos, which is in contrast
to the reduction in pre-osteoblast progenitors observed in our
Nedd4 knockout models. Interestingly, in our analyses we observed
reduced expression of Runx2 after deletion of Nedd4 in Osx ex-
pressing cells. Given the reduction in the number of Osx-positive
cells observed with Cre-GFP staining, the reduced expression of
Runx2 in Osx-Cre; Nedd4ﬂ/ embryos likely represents hypoplasia
of the pre-osteoblast progenitor pool rather than a role for Nedd4
in feed-back regulation of Runx2 expression.
Nedd4 is the prototypic member of the C-terminal HECT do-
main family of E3 ubiquitin ligases that comprise N-terminal C2
domains and WW domains controlling substrate recognition (Ro-
tin and Kumar, 2009; Kumar et al., 1997). Identifying molecular
targets of Nedd4 in pre-osteoblasts now poses the next challenge
in deﬁning the mechanisms by which Nedd4 controls osteoblast
proliferation and/or differentiation. As Nedd4 predominantly tar-
gets proteins for non-degradative modiﬁcations (Fukushima et al.,
2015; Fujii et al., 2013) this presents a major challenge in identi-
fying Nedd4 targets in vivo. Several established targets of Nedd4
are known to play roles in bone development. One such target is
phospho-SMAD1, which signals downstream of BMP to activate
osteoblast differentiation programmes (Chen et al., 2012). Nedd4
has previously been shown to negatively regulate phospho-
SMAD1 in in vitro cell culture models (Kim et al., 2011), suggesting
that loss of Nedd4 may induce precocious activation of phospho-
SMADs and premature osteoblast differentiation. However, this
was not observed in vivo in our present study. Therefore it is likely
that Nedd4 regulates target proteins differentially in a cell type-
speciﬁc manner. Of the other established targets of Nedd4, a
strong candidate for controlling pre-osteoblast proliferation may
be the IGF signalling pathway. Nedd4 positively regulates IGF
signalling through controlling the abundance and activity of IGF1R
(Cao et al., 2008) which has an essential role in bone growth and
development (Guntur and Rosen, 2013). However, whether this or
other targets of Nedd4 play important roles in osteoblast growth
dynamics remain to be explored.In conclusion, our data identify a previously unknown role for
Nedd4 in osteoblast formation and deﬁne a critical time window
downstream of osteoblast speciﬁcation at which Nedd4 is required
for bone growth and craniofacial development. Nedd4 / and
conditional knockout mice therefore represent novel models to
decipher the mechanisms controlling craniofacial development
and the origins of craniofacial birth defects.4. Materials and methods
4.1. Mouse strains
All experiments were carried out in accordance with ethical
guidelines of the SA Pathology Animal Ethics Committee. To re-
move Nedd4 speciﬁcally in NCCs we crossed Wnt1-Cre;Nedd4þ /
males to Nedd4ﬂ/ﬂ females. To remove Nedd4 speciﬁcally in me-
senchymal precursors of bone and cartilage we crossed Prx1-Cre;
Nedd4þ / males to Nedd4ﬂ/ﬂ females (Logan et al., 2002). To re-
move Nedd4 speciﬁcally in osteoblast precursors we crossed Osx-
Cre/EGFP;Nedd4þ / males to Nedd4ﬂ/ﬂ females (Rodda and
McMahon, 2006). Nedd4 / mice and Nedd4ﬂ/ﬂ (generously pro-
vided by Dr Hiroshi Kawabe, Max-Planck Institute of Medical Re-
search) have been described previously (Cao et al., 2008; Kawabe
et al., 2010). To lineage trace Osx positive osteoblasts we crossed
Osx-Cre/EGFP mice to R26RLacZ reporter mice. Genotyping for Cre
and the Nedd4 alleles has been described previously (Cao et al.,
2008; Kawabe et al., 2010). To obtain mouse embryos of deﬁned
gestational ages, mice were mated in the evening and the morning
of vaginal plug formation was counted as E0.5.
4.2. Skeletal preparations
Staining of bone and cartilage was carried out on E17.5 embryos
ﬁxed overnight in 95% ethanol then skinned and eviscerated.
Embryos were placed in acetone for 2 days before being placed
into a solution containing 1 volume of 0.3% Alcian Blue 8GS in 70%
ethanol, 1 volume of 0.1% Alizarin Red S in 95% ethanol, 1 volume
acetic acid and 17 volumes of 70% ethanol for 3 days. Embryos
were then washed in water and macerated in 1% KOH for 1 day and
then decolorised in 20% glycerol in 1% KOH for 1–2 days and
prepared in increasing concentrations of glycerol to a ﬁnal con-
centration of 100% glycerol.
4.3. Histology and Immunolabelling
Embryos were ﬁxed in 4% paraformaldehyde in PBS and cryo-
sectioned at 12 μm thickness (Leica). Von Kossa (1% silver nitrate)
staining was used to mark areas of mineralisation, alkaline phos-
phatase staining (0.5 mg/ml NBT/BCIP) was used to mark osteo-
blast activity and Alcian blue (0.1% Alcian blue in 0.1 M HCl) was
used to mark cartilage. Histological markers were counterstained
with eosin. High resolution images were recorded on an IX81 in-
verted microscope (Olympus) equipped with an OCRA-ER digital
CCD camera (Hamamatsu) and processed with CellR software
(Olympus).
For immunolabelling, cryosections were blocked in 10% DAKO
blocking solution, 0.2% Triton X-100 in PBS, and stained with the
indicated primary antibodies. Antibodies used: chicken anti-GFP
(Abcam) 1:1000; rabbit anti-cleaved caspase 3 (Cell Signalling
Technology) 1:500; rabbit anti-phospho-Histone H3 (Millipore)
1:500; goat anti-Sox10 (Santa Cruz); rabbit anti-phospho-SMAD1/5/
8 (Cell Signalling Technology). Cyrosections were mounted in Pro-
long Gold antifade reagent with DAPI (Molecular Probes). Confocal
images were acquired on a LSM 700 (Zeiss) system. All ﬁgures were
constructed in Adobe Photoshop CS4 (Adobe Systems, Inc.).
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Section in situ hybridisation was performed as described
(Schwarz et al., 2004). Riboprobes were transcribed from plasmids
containing cDNA sequences for Isl1, Col1a1, Runx2, Osx, and BSP.
For each probe, control and mutant embryos were developed for
the same amount of time. High resolution images were recorded
on an IX81 inverted microscope (Olympus) equipped with an
OCRA-ER digital CCD camera (Hamamatsu) and processed with
CellR software (Olympus).
4.5. β-Galactosidase staining
Cryosections were incubated in staining solution: 19 mM So-
dium dihydrogen phosphate, 81 mM Disodium hydrogen phos-
phate, 2 mM MgCl2, 5 mM EGTA, 0.01% Sodium deoxycholate,
0.02% NP-40, 5 mM Potassium ferricyanide, 5 mM Potassium fer-
rocyanide and 1 mg/ml X-gal substrate, at 37 °C until blue staining
was sufﬁcient.
4.6. EdU administration
EdU (5-ethynyl-2′-deoxyuridine) (Life technologies) was pre-
pared in 0.9% NaCl solution at 10 mg/ml and stored at 20 °C until
use. To label proliferating cells EdU was delivered by in-
traperitoneal injections to pregnant dams at E12.5 at 100 mg/kg of
body weight. Embryos were collected from pregnant dams 2 h
after injection. Cryosections of EdU labelled embryos were in-
cubated with Click-iT EdU Kit Alexa-594 conjugated (Life Tech-
nologies) following staining with primary antibodies.
4.7. TUNEL staining
TUNEL staining was performed using the TMR Red In Situ Cell
Death Detection Kit (Roche), following the manufacturers
recommendations.
4.8. MicroCT analysis
Adult skulls were collected and ﬁxed in 95% EtOH. Ex vivo mi-
cro-CT was performed using a micro-CT system (Skyscan 1076,
Brussels, Belgium) at a resolution of 26 μm/pixel. Reconstructed
X-ray images were realigned to generate 3D projections that were
rotated to form dorsal and lateral views.Acknowledgements
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